THERAPEUTIKUM FÜR MORBUS HUNTER

Patent europeic · EP3318267 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3318267
Numer da la dumonda
EP16818303
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
04-07-2016
Publitgà
09-05-2018
Concedì
24-02-2021
Stritgà
23-02-2022
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 38/16 (2006.01)
A61K 9/00 (2006.01)
A61P 25/00 (2006.01)
Prioritad
US 201562187867 P 02.07.2015
KR 20150187297 28.12.2015
Dumonda PCT
PCT/KR2016/007203 04.07.2016
Publicaziun PCT
WO2017/003270 05.01.2017
Lingua da l’annunzia
corean
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-02-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.02.2022

  2. 05-01-2022

    Midada

    Published in Swissreg on 05.01.2022

  3. 24-02-2021

    Concedì

    Published in Swissreg on 24.02.2021

Partidas

Possessur

Medigenebio Corporation

107 Ihyeon-ro 30beon-gil Giheung-gu Yongin-si, Gyeonggi-do 446-855, KR

Green Cross Corporation

(Bojeong-dong) 107 Ihyeon-ro 30beon-gil Giheung-gu, Yongin-si, Gyeonggi-do 16924, KR

Inventur

LEE, Kyu-Hyun

Yongin-si Gyeonggi-do 16924, KR

BYUN, Han-Yeul

Yongin-si Gyeonggi-do 16924, KR

JUNG, Myung-Eun

Yongin-si Gyeonggi-do 16924, KR

LEE, Jin-Kyung

Yongin-si Gyeonggi-do 16924, KR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.